As people age, the chances of developing chronic inflammatory diseases such as rheumatoid arthritis, ulcerative colitis, or psoriatic arthritis increase. Fortunately, medical advancements continue to provide new treatment options. Two names that have recently gained traction in the field of autoimmune and inflammatory diseases are Rinvoq and Velsipity. But how do these treatments work, especially for seniors? What should older adults know before starting them?
This guide will explore Rinvoq treatment, Velsipity, and how these therapies can be potentially life-changing for seniors dealing with painful, chronic conditions.
Related: Weight Loss Pills for Diabetics: Managing Weight and Blood Sugar
Understanding Rinvoq: What Is It?
Rinvoq (generic name: upadacitinib) is a Janus kinase (JAK) inhibitor, a type of medication designed to interfere with the inflammatory process by blocking the activity of JAK enzymes in the body. Developed by AbbVie, Rinvoq is an oral prescription medication approved by the FDA for the treatment of:
- Rheumatoid arthritis (RA)
- Psoriatic arthritis (PsA)
- Atopic dermatitis (eczema)
- Ankylosing spondylitis (AS)
- Ulcerative colitis (UC)
- Crohn’s disease
For seniors, Rinvoq offers a non-injection alternative that may be easier to manage than biologic therapies requiring IV infusions or subcutaneous injections.
What Is Velsipity?
Velsipity (generic name: etrasimod) is a relatively new treatment developed for ulcerative colitis, a type of inflammatory bowel disease (IBD). It belongs to a class of drugs known as S1P receptor modulators, which work by reducing the activity of the immune system, specifically the movement of certain white blood cells (lymphocytes) into the gut lining where inflammation occurs.
Velsipity is taken orally once daily, making it another convenient option for patients who prefer pills over injections or hospital visits.
Rinvoq Treatment Velsipity for Seniors: Why It Matters
Aging adults face unique challenges when it comes to managing chronic inflammatory diseases. Their immune systems naturally weaken over time, and they often have other health conditions like high blood pressure, diabetes, or osteoporosis. Here's why Rinvoq treatment and Velsipity are especially relevant:
1. Convenience and Compliance
For seniors, the ease of taking a daily oral medication (like Rinvoq or Velsipity) significantly increases the likelihood of treatment adherence. In contrast to biologics, which often require a healthcare provider’s administration, these pills offer more independence.
2. Reduced Inflammation
Both medications are designed to target the root cause of inflammation rather than simply managing symptoms. This can improve mobility, reduce fatigue, and enhance quality of life—critical for older adults who may already struggle with physical limitations.
3. Improved Symptom Management
In clinical trials, Rinvoq has demonstrated substantial benefits in reducing joint pain, stiffness, and swelling, while Velsipity has shown effectiveness in reducing bowel urgency, diarrhea, and rectal bleeding.
Key Differences Between Rinvoq and Velsipity
Feature | Rinvoq | Velsipity |
---|---|---|
Type of Drug | JAK Inhibitor | S1P Receptor Modulator |
Conditions Treated | RA, PsA, eczema, UC, Crohn's, AS | Ulcerative Colitis |
Administration | Oral tablet, once daily | Oral tablet, once daily |
FDA Approval | Multiple autoimmune conditions | Approved for UC (2023) |
Target Audience | Broad (including seniors) | Primarily IBD patients |
Is Rinvoq Safe for Seniors?
Rinvoq treatment can be effective for seniors, but it’s not without risks. Since it modulates the immune system, it may increase the risk of infections, such as:
- Tuberculosis (TB)
- Shingles
- Bacterial infections
In some cases, Rinvoq has been associated with a slightly increased risk of cardiovascular events, blood clots, and cancer, especially in older adults and those who smoke or have other comorbidities.
Common Side Effects of Rinvoq:
- Upper respiratory tract infections
- Headaches
- Nausea
- Elevated liver enzymes
- Increased cholesterol levels
Seniors should have a thorough evaluation by their healthcare provider before starting Rinvoq. This includes baseline lab tests, infection screenings, and cardiovascular assessments.
What About Velsipity Safety in Older Adults?
Since Velsipity is newer, especially in the senior population, long-term safety data is still being collected. However, like Rinvoq, it also affects the immune system and may carry risks such as:
- Bradycardia (slow heart rate)
- Liver issues
- Eye problems (macular edema)
- Infections
It’s critical that senior patients using Velsipity undergo regular monitoring, including:
- ECGs (to check heart rhythm)
- Liver function tests
- Eye exams
- Blood tests
Who Should NOT Take Rinvoq or Velsipity?
While both drugs can be effective, Rinvoq treatment Velsipity options may not be suitable for every senior. Your doctor may avoid prescribing them if you have:
- Severe liver disease
- Active or chronic infections
- History of blood clots
- Certain cancers
- Severe heart conditions
How Do Rinvoq and Velsipity Compare to Biologics?
Biologic medications like Humira, Enbrel, or Stelara have been mainstays in treating autoimmune conditions. However, they often:
- Require injections or infusions
- Are more expensive
- Can cause injection-site reactions
In contrast, Rinvoq and Velsipity offer pill-based convenience. For seniors who struggle with injection schedules or fear needles, these treatments present an easier alternative with equal (or in some cases better) efficacy.
Related: Home Repair Grants for Seniors: How to Get a New Roof and More
Tips for Seniors Considering Rinvoq Treatment or Velsipity
If you or a loved one is exploring these options, here’s what to keep in mind:
- Discuss Comorbid Conditions: Let your doctor know about all existing health problems.
- Review Your Medications: Interactions may occur with blood thinners, antifungals, or heart medications.
- Stay on Top of Tests: Regular bloodwork and follow-ups are essential.
- Be Alert for Side Effects: Report any unusual fatigue, infections, vision changes, or shortness of breath.
- Lifestyle Support: Pairing medication with gentle exercise, an anti-inflammatory diet, and stress reduction helps improve outcomes.
Cost and Insurance Coverage
Both Rinvoq and Velsipity are branded drugs, meaning they can be expensive without insurance. Fortunately, most Medicare plans cover Rinvoq treatment and Velsipity if medically necessary. Patients can also explore:
- Manufacturer discount cards
- Patient assistance programs
- Coupon savings through platforms like GoodRx
Conclusion: Is Rinvoq Treatment Velsipity Right for Seniors?
Chronic inflammatory diseases can severely impact a senior’s mobility, independence, and overall well-being. Thankfully, innovative options like Rinvoq treatment and Velsipity are helping older adults take back control of their health.
While both offer effective symptom relief and improved quality of life, they do come with risks that must be managed through regular medical supervision. If you're a senior—or a caregiver for one—talk to your healthcare provider to determine whether Rinvoq or Velsipity is right for your unique health needs.